WENDY HOLT: Open Payments
NPI 1346407574 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,364 in 112 payments from 21 companies in 2025. Trend: 2023 $1,577 · 2024 $1,377 · 2025 $2,364
Food & beverage: $2,280Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $469 |
| Janssen Biotech, Inc. | 16 | $461 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $201 |
| PFIZER INC. | 8 | $198 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $138 |
| QOL Medical, LLC | 6 | $137 |
| Madrigal Pharmaceuticals | 5 | $129 |
| Phathom Pharmaceuticals, Inc. | 6 | $76 |
| Ipsen Biopharmaceuticals, Inc | 4 | $73 |
| Lilly USA, LLC | 3 | $69 |
Products named: TREMFYA, RINVOQ, ENTYVIO, VELSIPITY, XIFAXAN, Sucraid, REZDIFFRA, DUPIXENT.
Industry payments across VA — which companies pay providers there.
